Quest Diagnostics Incorporated (NYSE:DGX) entered into a definitive agreement to acquire Mobile Medical Examination Service, Inc (‘MedXM’) for approximately $150 million on January 23, 2018. The consideration paid for the transaction includes a cash payment of $130 million, net of $5 million cash acquired and a contingent consideration estimated at $12 million dependent upon the achievement of certain revenue targets. The transaction is expected to be completed in the first quarter of 2018. JMP Securities LLC acted as financial advisor to MedXM in connection with the transaction. David Lee of Latham & Watkins LLP acted as legal advisor to Mobile Medical Examination Services, Inc.